Actinogen Medical Limited

ASX:ACW Voorraadrapport

Marktkapitalisatie: AU$73.6m

Actinogen Medical Beheer

Beheer criteriumcontroles 2/4

Actinogen Medical's CEO is Steve Gourlay, appointed in Mar 2021, has a tenure of 3.67 years. total yearly compensation is A$754.11K, comprised of 54.7% salary and 45.3% bonuses, including company stock and options. directly owns 3.28% of the company’s shares, worth A$2.41M. The average tenure of the management team and the board of directors is 2.3 years and 6.9 years respectively.

Belangrijke informatie

Steve Gourlay

Algemeen directeur

AU$754.1k

Totale compensatie

Percentage CEO-salaris54.7%
Dienstverband CEO3.7yrs
Eigendom CEO3.3%
Management gemiddelde ambtstermijn2.3yrs
Gemiddelde ambtstermijn bestuur6.9yrs

Recente managementupdates

Recent updates

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Apr 30
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Nov 16
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Aug 02
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

Apr 12
We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Nov 28
We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Aug 09
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Apr 07
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Oct 24
We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

Jul 11
Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

Mar 27
We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Jan 07
How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Analyse CEO-vergoeding

Hoe is Steve Gourlay's beloning veranderd ten opzichte van Actinogen Medical's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024AU$754kAU$412k

-AU$13m

Mar 31 2024n/an/a

-AU$14m

Dec 31 2023n/an/a

-AU$15m

Sep 30 2023n/an/a

-AU$13m

Jun 30 2023AU$657kAU$396k

-AU$11m

Mar 31 2023n/an/a

-AU$11m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$10m

Jun 30 2022AU$955kAU$376k

-AU$9m

Mar 31 2022n/an/a

-AU$8m

Dec 31 2021n/an/a

-AU$7m

Sep 30 2021n/an/a

-AU$6m

Jun 30 2021AU$271kAU$112k

-AU$4m

Compensatie versus markt: Steve's total compensation ($USD498.06K) is above average for companies of similar size in the Australian market ($USD299.27K).

Compensatie versus inkomsten: Steve's compensation has increased whilst the company is unprofitable.

CEO

Steve Gourlay (65 yo)

3.7yrs

Tenure

AU$754,111

Compensatie

Dr. Steven G. Gourlay, also known as Steve, MBBS (M.D.), Ph D., FRACP, M.B.A., serves as Chief Executive Officer at Actinogen Medical Limited since March 15, 2021 and as its Managing Director and Director...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Steven Gourlay
MD, CEO & Director3.7yrsAU$754.11k3.28%
A$ 2.4m
William Souter
Chief Financial Officerless than a yearAU$476.62k0.014%
A$ 10.0k
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board1.8yrsAU$913.27kgeen gegevens
Michael Roberts
Head of Investor Relations & Corporate Communications3.5yrsgeen gegevensgeen gegevens
Paul Rolan
Head of Clinical Pharmacology & Lead Physician and Depression2.8yrsAU$191.66kgeen gegevens
Fujun Li
Head of Manufacturing1.3yrsgeen gegevensgeen gegevens
Andrew Udell
Chief Commercial Officerless than a yeargeen gegevensgeen gegevens
Peter Webse
Company Secretary11.1yrsgeen gegevensgeen gegevens

2.3yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren management: ACW's management team is considered experienced (2.3 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Steven Gourlay
MD, CEO & Director3.7yrsAU$754.11k3.28%
A$ 2.4m
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board2.8yrsAU$913.27kgeen gegevens
George Morstyn
Independent Non-Executive Director6.9yrsAU$114.27k0.41%
A$ 299.4k
Geoffrey Edward Brooke
Independent Non-Executive Chairman7.7yrsAU$234.39k0.64%
A$ 471.4k
Colin Masters
Member of Xanamem Clinical Advisory Board9.7yrsgeen gegevensgeen gegevens
Jeffrey Cummings
Member of Xanamem Clinical Advisory Board9.7yrsgeen gegevensgeen gegevens
Malcolm McComas
Independent Non-Executive Director5.6yrsAU$114.27k0.24%
A$ 179.3k
John Harrison
Member of Depression & Cognition Clinical Advisory Board2.8yrsgeen gegevensgeen gegevens
Craig Ritchie
Chairman of Xanamem Clinical Advisory Board9.7yrsgeen gegevensgeen gegevens
Jonathan Seckl
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Brian Walker
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Scott Webster
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens

6.9yrs

Gemiddelde duur

71yo

Gemiddelde leeftijd

Ervaren bestuur: ACW's board of directors are considered experienced (6.9 years average tenure).